國務院聯(lián)防聯(lián)控機制12月26日晚發(fā)布《關于對新型冠狀病毒感染實施“乙類乙管”的總體方案》，方案明確，優(yōu)化中外人員往來管理。

來華人員在行前48小時進行核酸檢測，結(jié)果陰性者可來華，無需向我駐外使領館申請健康碼，將結(jié)果填入海關健康申明卡。如呈陽性，相關人員應在轉(zhuǎn)陰后再來華。取消入境后全員核酸檢測和集中隔離。健康申報正常且海關口岸常規(guī)檢疫無異常者，可放行進入社會面。取消“五個一”及客座率限制等國際客運航班數(shù)量管控措施。各航司繼續(xù)做好機上防疫，乘客乘機時須佩戴口罩。進一步優(yōu)化復工復產(chǎn)、商務、留學、探親、團聚等外籍人士來華安排，提供相應簽證便利。逐步恢復水路、陸路口岸客運出入境。根據(jù)國際疫情形勢和各方面服務保障能力，有序恢復中國公民出境旅游。

On late December 26th, 2022, the National Health Commission issued a notice General Program for the Implementation of "Category B" Management of Novel Coronavirus Infection. Below are specific policies:

① The Covid-19 pneumonia was renamed as novel coronavirus infection.

② The management of the disease will be downgraded from Class A to Class B in accordance with the Law of the People's Republic of China on Prevention and Treatment of Infectious Disease, starting January 8. Passengers traveling to China need to take nucleic acid test within 48 hours before boarding their flights to China, and nucleic acid screenings and centralized isolation after arrival will be canceled. In light of the international epidemic situation and service capacity, the outbound travel of Chinese citizens will be resumed in an orderly manner.